LIXT Stock Analysis: Buy, Sell, or Hold?
LIXT - Lixte Biotechnology Holdings, Inc. Common Stock
$3.05
-0.02 (-0.49%)
▼
5d:
+2.87%
30d:
+8.54%
90d:
-22.39%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Get Alerted When LIXT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LIXT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: LIXT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: LIXT is currently trading at $3.05, which is considered slightly high relative to its 30-day fair value range of $2.71 to $3.10.
Technical Outlook: Technically, LIXT is in a strong downtrend. Immediate support is located at $2.60, while resistance sits at $3.24.
Market Sentiment: LIXT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LIXT is in a strong downtrend. Immediate support is located at $2.60, while resistance sits at $3.24.
Market Sentiment: LIXT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.71 -
$3.10
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
76.5%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
Fair Price Analysis
30-Day Fair Range
$2.71 -
$3.10
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.60
Resistance Level
$3.24
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Share & Embed Analysis
Last updated: April 03, 2026 3:31 AM ET
Data refreshes hourly during market hours. Next update: 4:31 AM
Data refreshes hourly during market hours. Next update: 4:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIXT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 61 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$290 | 53 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 53 HOLD |
